Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.
종목 코드 MOBI
회사 이름Mobia Medical Inc
상장일May 08, 2026
CEOFoust (Richard John)
직원 수- -
유형Ordinary Share
회계 연도 종료- -
주소2802 Flintrock Trace, Suite 226
도시
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호78738
전화
웹사이트
종목 코드 MOBI
상장일May 08, 2026
CEOFoust (Richard John)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음